References
- Ilzecka J, Stelmasiak Z. Creatine kinase activity in amyotrophic lateral sclerosis patients. Neurol Sci. 2003;24: 286–7.
- Chahin N, Sorenson EJ. Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve. 2009;40:126–9.
- Felice KJ, North WA. Creatine kinase values in amyotrophic lateral sclerosis. J Neurol Sci. 1998;160 (Suppl 1):S30–2.
- Panitch HS, Franklin GM. Elevation of serum creatine phosphokinase in amyotrophic lateral sclerosis. Neurology. 1972;22:964–6.
- Amrit AN, Anderson MS. Serum creatine phosphokinase in amyotrophic lateral sclerosis. Correlation with gender, duration, and skeletal muscle biopsy. Neurology. 1974; 24:834–7.
- Sinaki M, Mulder DW. Amyotrophic lateral sclerosis: relationship between serum creatine kinase level and patient survival. Arch Phys Med Rehabil. 1986;67:169–71.
- Lima AF, Evangelista T, de Carvalho M. Increased creatine kinase and spontaneous activity on electromyography, in amyotrophic lateral sclerosis. Electromyogr Clin Neurophysiol. 2003;43:189–92.
- Harrington TM, Cohen MD, Bartleson JD, Ginsburg WW. Elevation of creatine kinase in amyotrophic lateral sclerosis. Potential confusion with polymyositis. Arthritis Rheum. 1983;26:201–5.
- Edmonds PJ, Ziegler DK. Diagnostic value of serum creatine phosphokinase in motor neuron disease. South Med J. 1975;68:1388–90.
- Williams ER, Bruford A. Creatine phosphokinase in motor neuron disease. Clin Chim Acta. 1970;27:53–6.
- Dawson DM. Leakage of enzymes from denervated and dystrophic chicken muscle. Arch Neurol. 1966;14:321–5.
- Ernster L, Ikkos D, Luft R. Enzymic activities of human skeletal muscle mitochondria: a tool in clinical metabolic research. Nature. 1959;184:1851–4.
- Achari AN, Anderson MS. Myopathic changes in amyotrophic lateral sclerosis. Pathologic analysis of muscle biopsy changes in 111 cases. Neurology. 1974;24:477–81.
- Kasarskis EJ, Mendiondo MS, Wells S, Malguizo MS, Thompson M, Healey M, et al. The ALS Nutrition/NIPPV Study: design, feasibility, and initial results. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2011;12:17–25.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
- Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73: 1227–33.
- Ashworth B. Preliminary Trial of Carisoprodol in Multiple Sclerosis. The Practitioner. 1964;192:540–2.
- Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd edn. Hoboken, New Jersey: John Wiley & Sons; 2002.
- Farinde A. Lab Values, Normal Adult http://emedicine.medscape.com/article/2172316-overview: medscape; 2014 (updated 5/20/2014; cited 2014 10/20/2014).